| Pharmaceutical active ingredients: |
| Methylphenidate Hydrochloride |
| Available forms, composition and doses of Riphenidate: |
| N / A |
| Riphenidate medical category: |
| Human:Anorexigenic agents and respiratory and cerebral stimulantsCNS drugs and agents for ADHD |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N06BA04 - Methylphenidate |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| RatiopharmTechnilab Pharma |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
PHL-Methylphenidate | Methylphenidate Hydrochloride | Pharmel |
| PMS-Methylphenidate | Methylphenidate Hydrochloride | Pharmascience |
| Prohiper | Methylphenidate Hydrochloride | Mersifarma Tirmaku Mercusana |
| Ratio-Methylphenidate | Methylphenidate Hydrochloride | Ratiopharm |
| Rilatine | Methylphenidate Hydrochloride | Novartis |
| Ritalin | Methylphenidate Hydrochloride | Novartis; Four Star; Mitra Healthcare; Zuellig Pharma |
| Ritalin LA | Methylphenidate Hydrochloride | Novartis; Four Star; Mitra Healthcare; Zuellig Pharma |
| Ritalin SR | Methylphenidate Hydrochloride | Novartis; Mitra Healthcare; Zuellig Pharma |
| Ritalin Uno | Methylphenidate Hydrochloride | Novartis |
| Ritalina | Methylphenidate Hydrochloride | Novartis |